Inhibition of Autoimmune Disease in a Murine Model of Systemic Lupus Erythematosus Induced by...

7

Transcript of Inhibition of Autoimmune Disease in a Murine Model of Systemic Lupus Erythematosus Induced by...

Page 1: Inhibition of Autoimmune Disease in a Murine Model of Systemic Lupus Erythematosus Induced by Exposure to Syngeneic Photoinactivated Lymphocytes
Page 2: Inhibition of Autoimmune Disease in a Murine Model of Systemic Lupus Erythematosus Induced by Exposure to Syngeneic Photoinactivated Lymphocytes
Page 3: Inhibition of Autoimmune Disease in a Murine Model of Systemic Lupus Erythematosus Induced by Exposure to Syngeneic Photoinactivated Lymphocytes
Page 4: Inhibition of Autoimmune Disease in a Murine Model of Systemic Lupus Erythematosus Induced by Exposure to Syngeneic Photoinactivated Lymphocytes
Page 5: Inhibition of Autoimmune Disease in a Murine Model of Systemic Lupus Erythematosus Induced by Exposure to Syngeneic Photoinactivated Lymphocytes
Page 6: Inhibition of Autoimmune Disease in a Murine Model of Systemic Lupus Erythematosus Induced by Exposure to Syngeneic Photoinactivated Lymphocytes
Page 7: Inhibition of Autoimmune Disease in a Murine Model of Systemic Lupus Erythematosus Induced by Exposure to Syngeneic Photoinactivated Lymphocytes

Autoantibodies Affect Brain Density Reduction in Nonneuropsychiatric Systemic Lupus Erythematosus Patients

Autoantibodies Affect Brain Density Reduction in Nonneuropsychiatric Systemic Lupus Erythematosus Patients

Functional outcome after stroke in patients with rheumatoid arthritis and systemic lupus erythematosus

Functional outcome after stroke in patients with rheumatoid arthritis and systemic lupus erythematosus

Systemic lupus erythematosus and pregnancy - Elsevier

Systemic lupus erythematosus and pregnancy - Elsevier

Antigen-Specific Tolerance Induced by Autoimmunization with Photoinactivated Syngeneic Effector Cells

Antigen-Specific Tolerance Induced by Autoimmunization with Photoinactivated Syngeneic Effector Cells

Impact of health maintenance organizations and fee-for-service on health care utilization among people with systemic lupus erythematosus

Impact of health maintenance organizations and fee-for-service on health care utilization among people with systemic lupus erythematosus

Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor α protective

Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor α protective

A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus

A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus

Lack of the Long Pentraxin PTX3 Promotes Autoimmune Lung Disease but not Glomerulonephritis in Murine Systemic Lupus Erythematosus

Lack of the Long Pentraxin PTX3 Promotes Autoimmune Lung Disease but not Glomerulonephritis in Murine Systemic Lupus Erythematosus

Paniculitis en las enfermedades del tejido conectivo, lupus y ...

Paniculitis en las enfermedades del tejido conectivo, lupus y ...

Expression of human leukocyte antigen-G in systemic lupus erythematosus

Expression of human leukocyte antigen-G in systemic lupus erythematosus

Profils clinico-biologiques associés à la présence d'un lupus ...

Profils clinico-biologiques associés à la présence d'un lupus ...

A Functional Variant in MicroRNA146a Promoter Modulates Its Expression and Confers Disease Risk for Systemic Lupus Erythematosus

A Functional Variant in MicroRNA146a Promoter Modulates Its Expression and Confers Disease Risk for Systemic Lupus Erythematosus

Effect of Prolactin on Lymphocyte Activation from Systemic Lupus Erythematosus Patients

Effect of Prolactin on Lymphocyte Activation from Systemic Lupus Erythematosus Patients

Identification of MAMDC1 as a Candidate Susceptibility Gene for Systemic Lupus Erythematosus (SLE

Identification of MAMDC1 as a Candidate Susceptibility Gene for Systemic Lupus Erythematosus (SLE

Identification of miRNAs as potential modulators of tissue factor expression in patients with systemic lupus erythematosus and antiphospholipid syndrome

Identification of miRNAs as potential modulators of tissue factor expression in patients with systemic lupus erythematosus and antiphospholipid syndrome

Oxidized Low-Density Lipoprotein/b 2 Glycoprotein I Complexes and Autoantibodies to oxLig-1/b 2 Glycoprotein I in Patients With Systemic Lupus Erythematosus and Antiphospholipid Syndrome

Oxidized Low-Density Lipoprotein/b 2 Glycoprotein I Complexes and Autoantibodies to oxLig-1/b 2 Glycoprotein I in Patients With Systemic Lupus Erythematosus and Antiphospholipid Syndrome

Lupus Nephritis in Childhood

Lupus Nephritis in Childhood

Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus

Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus

Pharmacokinetics and Pharmacodynamics of Mycophenolic Acid and Their Relation to Response to Therapy of Childhood-Onset Systemic Lupus Erythematosus

Pharmacokinetics and Pharmacodynamics of Mycophenolic Acid and Their Relation to Response to Therapy of Childhood-Onset Systemic Lupus Erythematosus

MicroRNA125a contributes to elevated inflammatory chemokine RANTES via targeting KLF13 in systemic lupus erythematosus

MicroRNA125a contributes to elevated inflammatory chemokine RANTES via targeting KLF13 in systemic lupus erythematosus